ESSEX INVESTMENT MANAGEMENT CO LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 201772
BOSTON, MA
Position in XERS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,337,060
-$1,429,016 QoQ
Shares Held
747,769
+1.8% QoQ
Ownership
0.433%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 52.130136445881014.ToString("F0")%
Shared 0.ToString("F0")%
None 47.869863554118986.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ESSEX INVESTMENT MANAGEMENT CO LLC holds $19,841,445 across 5 Drug Manufacturers - Specialty & Generic names. XERS ranks #2 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
249,278 | $12,002,735 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
747,769 | $4,337,060 | |
| 3 | LQDA |
Liquidia Corp
|
78,171 | $2,950,173 | |
| 4 | ETON |
Eton Pharmaceuticals, Inc.
|
20,182 | $498,091 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
4,295 | $53,386 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,337,060 | 747,769 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,766,076 | 734,532 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,105,276 | 750,034 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,389,364 | 725,774 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,010,137 | 730,444 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,610,097 | 474,955 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||